0 Reacties
0 aandelen
186 Views
0 voorbeeld
Zoeken
Ontdek nieuwe mensen, nieuwe verbindingen te maken en nieuwe vrienden maken
-
Please log in to like, share and comment!
-
Biosimilars and Demand Surge Shape Europe Adalimumab Market Landscape"Executive Summary Europe Adalimumab Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2022 to 2029 and is expected to reach USD 10,337.79 million by 2029 from USD 3,485.94 million in 2021. Each of the topics covered in the Europe Adalimumab report is studied...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Biosimilars and Follow-on Biologics Market to 2035 | USD 145.2B Growth at 14.1% CAGRThe global Biosimilars and Follow-on Biologics Market is witnessing rapid expansion, with market value estimated at USD 38.7 billion in 2025 and projected to reach USD 145.2 billion by 2035, growing at a CAGR of 14.1% during the forecast period. Growth is being driven by rising demand for cost-effective biologic therapies, increasing patent expirations of blockbuster biologic drugs, expanding...0 Reacties 0 aandelen 545 Views 0 voorbeeld
-
Biosimilars Market Expansion: Opportunities in Global Healthcare SectorGlobal Biosimilars Market Size, Share & Growth Forecast (2026–2034) The Global Biosimilars Market is projected to grow significantly from USD 22.7 billion in 2025 to USD 68.4 billion by 2033, expanding at a CAGR of 15.3% during the forecast period. Biosimilars, which are highly similar versions of approved biologic drugs, are gaining widespread adoption due to...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Biosimilars Market Size, Affordable Biologics and Pharmaceutical Innovation Trends Forecast to 2033Introduction The biosimilars market is experiencing rapid global expansion as healthcare systems increasingly seek cost-effective alternatives to high-priced biologic drugs. Biosimilars are biologic medical products highly similar to already approved reference biologics, with no clinically meaningful differences in safety, purity, or efficacy. Rising healthcare expenditure, growing prevalence...0 Reacties 0 aandelen 935 Views 0 voorbeeld
-
Biosimilars Market: Future Growth OpportunitiesIn the high-stakes world of modern medicine, we are currently witnessing a structural realignment of the pharmaceutical industry. If the early 2010s were defined by the "patent cliff" of small-molecule blockbusters like Lipitor, 2026 marks the dawn of a far more complex era. This is the year of the biological "super-cliff," where the Biosimilars Market 2026 is poised to bridge the gap...0 Reacties 0 aandelen 677 Views 0 voorbeeld
-
Biosimilars Market: Strategic Insights for Industry StakeholdersIn the high-stakes world of modern medicine, we are currently witnessing a structural realignment of the pharmaceutical industry. If the early 2010s were defined by the "patent cliff" of small-molecule blockbusters like Lipitor, 2026 marks the dawn of a far more complex era. This is the year of the biological "super-cliff," where the Biosimilars Market 2026 is poised to bridge the gap...0 Reacties 0 aandelen 610 Views 0 voorbeeld
-
From Branded Products to Biosimilars: The Evolution of the Insulin Glargine MarketInsulin Glargine Market According to the latest report published by Data Bridge Market Research, the Insulin Glargine Market The global insulin glargine market size was valued at USD 7.46 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 6.70% during the forecast period Insulin Glargine Market analysis report...0 Reacties 0 aandelen 491 Views 0 voorbeeld
-
Generic Biosimilars Market Growth: Biopharmaceutical Innovation, Affordable Biologics & Precision HealthcareGeneric Biosimilars Market: Affordable Biologic Therapies, Precision Healthcare & Biopharmaceutical Innovation (2025–2033) Written By Shubham Senior Biopharmaceutical & Healthcare Innovation Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a healthcare and pharmaceutical market research analyst specializing in biosimilars, biopharmaceutical manufacturing, precision...0 Reacties 0 aandelen 991 Views 0 voorbeeld
-
Generic Drug Manufacturing Market Growth: Biosimilars, AI Automation & Healthcare Accessibility Trends (2025–2033)Generic Drug Manufacturing Market: AI-Based Pharmaceutical Automation, Biosimilars Innovation & Affordable Healthcare Expansion (2025–2033) Written By Shubham Senior Pharmaceutical Manufacturing & Healthcare Market Analyst | M2Square ConsultancyExperience: 4+ Years Shubham is a pharmaceutical and healthcare market research analyst specializing in generic drug manufacturing,...0 Reacties 0 aandelen 1K Views 0 voorbeeld
-
Long-Acting Recombinant Hormone Biosimilars Market Advances with Growing Adoption of Biosimilar Therapies and Innovation in Biopharmaceutical DevelopmentAccording to the latest report published by Data Bridge Market Research, the Long-Acting Recombinant Hormone Biosimilars Market The global long-acting recombinant hormone biosimilars market size was valued at USD 198.00 million in 2025 and is expected to reach USD 421.35 million by 2033, at a CAGR of 9.90% during the forecast period Global Long-Acting Recombinant Hormone Biosimilars...0 Reacties 0 aandelen 342 Views 0 voorbeeld
-
Long-Acting Recombinant Hormone Biosimilars Market Expands with Rising Demand for Cost-Effective Biologics and Advanced Endocrine TherapiesAccording to the latest report published by Data Bridge Market Research, the Long-Acting Recombinant Hormone Biosimilars Market The global long-acting recombinant hormone biosimilars market size was valued at USD 198.00 million in 2025 and is expected to reach USD 421.35 million by 2033, at a CAGR of 9.90% during the forecast period The large scale Long-Acting Recombinant Hormone...0 Reacties 0 aandelen 350 Views 0 voorbeeld
-
Adalimumab Biosimilar Market Expands with Increasing Adoption of Cost-Effective Biologic TherapiesAccording to the latest report published by Data Bridge Market Research, the Adalimumab Biosimilar Market A talented team works strictly with their potential capabilities to produce the most excellent Adalimumab Biosimilar Market research report. To give clear idea about the current and future marketplace, most up to date market insights and analysis has been offered...0 Reacties 0 aandelen 12 Views 0 voorbeeld
-
Advancements in Biopharmaceuticals Accelerate the Global EPO Drugs MarketGlobal Demand Outlook for Executive Summary Erythropoietin (EPO) Drugs Market Size and Share CAGR Value Global Erythropoietin (EPO) Drugs Market report is a highly visual business report where the key market research findings have been organized, analyzed, and summarized neatly. This report can be communicated more effectively with a team, stakeholders, and customers. With devotion,...0 Reacties 0 aandelen 2K Views 0 voorbeeld
-
Anti-Cancer Drug Market Companies: Growth, Share, Value, Size, and Insights"Executive Summary Anti-Cancer Drug Market: Share, Size & Strategic Insights Data Bridge Market Research analyses that the global anti-cancer drug market which was USD 1,20,000.00 million in 2022, would rocket up to USD 2,97,000.00 million by 2030, and is expected to undergo a CAGR of 12.0% during the forecast period. The Anti-Cancer Drug report provides CAGR values along with its...0 Reacties 0 aandelen 27K Views 0 voorbeeld
-
EPO Drugs Market Expands with Rising Demand for Anemia Treatment SolutionsAccording to the latest report published by Data Bridge Market Research, the Erythropoietin (EPO) Drugs Market CAGR Value A team involved in preparing this Erythropoietin (EPO) Drugs Market research report has kept certain things into focus that include the minds of target markets, feelings, preferences, attitudes, convictions and value systems. The global business report...0 Reacties 0 aandelen 610 Views 0 voorbeeld
-
Erythropoietin (EPO) Drugs Market: Rising Chronic Disease Cases Driving Demand for EPO TherapiesAccording to the latest report published by Data Bridge Market Research, the Erythropoietin (EPO) Drugs Market CAGR Value A large scale Erythropoietin (EPO) Drugs Market research reports help business or organization in every sphere of trade to take better decisions, to respond the toughest business questions and reduce the risk of failure. Global market research analysis...0 Reacties 0 aandelen 538 Views 0 voorbeeld
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Reacties 0 aandelen 698 Views 0 voorbeeld
-
Global Microbial Fermentation APIs Market Growing at 1.5% CAGR Through 2032According to a new report from Intel Market Research, the global Microbial Fermentation APIs market was valued at USD 27.57 billion in 2024 and is projected to reach USD 30.56 billion by 2032, exhibiting a steady CAGR of 1.5% during the forecast period (2025–2032). This growth is driven by the increasing demand for antibiotics, amino acids, and vitamins, particularly in emerging economies...0 Reacties 0 aandelen 576 Views 0 voorbeeld
-
Growing Demand for Anemia Therapies Drives the EPO Drugs MarketAccording to the latest report published by Data Bridge Market Research, the Erythropoietin (EPO) Drugs Market CAGR Value Market insights provided in the most excellent Erythropoietin (EPO) Drugs Market report, it becomes easy to gain a more precise understanding of the market landscape, issues that may take place for the Erythropoietin (EPO) Drugs Market industry in the future,...0 Reacties 0 aandelen 277 Views 0 voorbeeld
Zoekresultaten
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek